Patents by Inventor Brian Andrew Hills

Brian Andrew Hills has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicaments for asthma treatment
    Patent number: 7473416
    Abstract: A method and apparatus are disclosed for treating asthma and other respiratory conditions. A medicament comprising a surface active phospholipid (SAPL) is prepared in the form of a fine powder and administered to the lungs in a gas stream. A preferred SAPL is a solid blend of diplamitoyl choline and phosphatdiyl glycerol (PG).
    Type: Grant
    Filed: November 1, 2004
    Date of Patent: January 6, 2009
    Assignee: Britannia Pharmaceuticals, Ltd.
    Inventors: Audrey Egerton Hills, legal representative, Derek Alan Woodcock, Brian Andrew Hills
  • Anti-asthmatic combinations comprising surface active phospholipids
    Patent number: 7273604
    Abstract: Disclosed is a combination product for use in treating asthma and other respiratory conditions comprising a medicament comprising a surface active phospholipid composition in the form of a fine powder and an antiasthma drug. The product is arranged to be administered to the lungs by inhalation, for example, by the disclosed devices.
    Type: Grant
    Filed: October 27, 2004
    Date of Patent: September 25, 2007
    Assignee: Britannia Pharmaceuticals Limited
    Inventors: Brian Andrew Hills, Derek Alan Woodcock, John Nicholas Staniforth
  • Anti-asthmatic combinations comprising surface active phospholipids
    Patent number: 6824761
    Abstract: Disclosed is a combination product for use in treating asthma and other respiratory conditions comprising a medicament comprising a surface active phospholipid composition in the form of a fine powder and an antiasthma drug. The product is arranged to be administered to the lungs by inhalation, for example, by the disclosed devices.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: November 30, 2004
    Assignee: Britannia Pharmaceuticals Limited
    Inventors: Brian Andrew Hills, Derek Alan Woodcock, John Nicholas Staniforth
  • Use of phospholipids for the manufacture of a medicament for the prevention of adhesions
    Patent number: 6719960
    Abstract: A medicament is disclosed for reducing the risk of cross-healing (“adhesions”) after surgery. The medicament is a dry powder comprising a surface active phospholipid which is capable of binding to mesothical membranes, and a spreading agent. The medicament is applied as a dry powder to the surgical wound site.
    Type: Grant
    Filed: August 10, 2000
    Date of Patent: April 13, 2004
    Assignee: Britannia Pharmaceuticals Ltd.
    Inventors: Brian Andrew Hills, Derek Alan Woodcock
  • Use of surface active agent for the manufacture of a medicament for treatment of disorders of the middle ear
    Patent number: 6395295
    Abstract: The invention relates to the treatment of serous otitis media (glue ear). A medicament is disclosed which comprises a surface active phospholipid (SAPL) which is instilled as a powder into the middle ear. The SAPL has an affinity for the surface of the Eustachian tube and forms a film over its surface which prevents or deters reblockage of the tube.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: May 28, 2002
    Assignee: Britannia Pharmaceuticals Limited
    Inventors: Brian Andrew Hills, Derek Alan Woodcock
  • Phospholipid and propylene glycol based lubricant
    Patent number: 6133249
    Abstract: A method of lubrication of a mammalian joint or other physiological articulation which comprises administering a composition comprising one or more phospholipids in association with propylene glycol.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: October 17, 2000
    Assignee: MacNaught Medical Pty Limited
    Inventor: Brian Andrew Hills